NCT01694264 Study of Anti-Viral Prophylaxis for HBsAg(+) or HBcAb(+)/HBsAb(-) Patients Starting Anti-TNFα Status TERMINATED Phase PHASE3
NCT01679769 Prospective Study In Noninvasive Evaluation of Hepatic Fibrosis in Chronic Hepatitis B Status COMPLETED Phase N/A
NCT01671787 A Phase 1b Study Assessing GS-7340 in Treatment-Naive Adults With Chronic Hepatitis B Status COMPLETED Phase PHASE1
NCT01651403 Study to Evaluate the Antiviral Efficacy, Safety and Tolerability of Tenofovir Disoproxil Fumarate Versus Placebo in Pediatric Participants With Chronic Hepatitis B Infection Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT01627223 Comparison Between Lamivudine and Entecavir Treatment in Spontaneous Severe Acute Exacerbation Status TERMINATED Phase PHASE4
NCT01595633 Switch From Adefovir to Tenofovir in Chronic Hepatitis B for Suboptimal Response to Adefovir-based Combination Therapy Status UNKNOWN Phase PHASE4
NCT01594905 Entecavir Plus Tenofovir Combination in Subjects With Multi-drug Resistant Chronic Hepatitis B Virus Infection Status UNKNOWN Phase PHASE4
NCT01589952 Pegylated Interferon and Entecavir Combination in Chronic Hepatitis B (CHB) Status UNKNOWN Phase PHASE1/PHASE2
NCT01588912 Efficacy of Telbivudine With or Without add-on Tenofovir According to Roadmap Strategy Compare With Entecavir Status UNKNOWN Phase PHASE4
NCT01546116 Adefovir and Lamivudine for Entecavir Resistance (ALTER Study) Status COMPLETED Phase PHASE4
NCT01533051 Prospective Observational Cohort Study for the Durability of Anti-viral Therapy in Patients With Chronic Hepatitis B Status UNKNOWN Phase N/A
NCT01532843 Lowering Viral Load With Nucleos(T)Ide Analogues Prior to Peginterferon Treatment to Ncrease Sustained Response in CHB Status COMPLETED Phase PHASE4
NCT01531166 A Cohort Study in Korean Patients With Chronic Hepatitis B (CHB) Receiving Pegylated Interferon Status COMPLETED Phase N/A
NCT01524679 Peg-interferon ADDed to an Ongoing Nucleos(t)Ide Based Treatment in Patients With Chronic Hepatitis B to Induce Decrease of HBs-Antigen Status COMPLETED Phase PHASE2
NCT01491295 Switch to Tenofovir Versus Continue Lamivudine/Adefovir Treatment in Lamivudine-resistance Chronic Hepatitis B Patients Status UNKNOWN Phase PHASE4
NCT01487876 Efficacy and Safety of Dual-plasmid Hepatitis B Virus DNA Vaccine in Chronic Hepatitis B Patients Status UNKNOWN Phase PHASE2
NCT01471535 HBsAg Clearance in Inactive Chronic HBsAg Carriers After Interferon Treated Status COMPLETED Phase NA
NCT01464281 A Study of Switch From Nucleotide to Peginterferon Alfa-2a in CHB Patients Achieving HBeAg Loss and HBV DNA <200IU/ml Status UNKNOWN Phase NA